關鍵數據
0.953今開
0.989最高
8.26K成交量
虧損本益比TTM
虧損本益比動
--股利TTM
0.17%換手率
0.940昨收
0.906最低
7.76K成交額
虧損本益比靜
0.38市淨率
0.00%股息率 TTM
-128.83%ROA
13.54052週最高
0.07量比
-37.64M淨利潤
4.88M總股本
-1054.6482每股盈餘TTM
2.91Beta
-154.38%ROE
0.90652週最低
8.83%振幅
-123.13%毛利率
4.83M總市值
-3.25回報/風險
202.88%風險率

即將為您帶來更多新聞,敬請期待。 。 。
Co-Diagnostics Inc評分
0.01與上次評分對比預測8.00
財務診斷5.99
技術分析4.99
公司估值1.00
機構認同度3.00
風險評估1.71
分析師評級
Co-Diagnostics Inc 最新財報電話會記錄
Co-Diagnostics (CODX) 2026 年第二季法說會:FDA 遞件取得進展,惟現金下滑
Co-Diagnostics 2026 年第二季營收達 16.6 萬美元,虧損同步收窄,同時 CODX 已向 FDA 遞交其流感及 RSV(呼吸道融合病毒)檢測產品申請,期末持有 360 萬美元現金。
財務指標
貨幣: USD

由於公司未披露,未能獲取相關數據
貨幣: USD

由於公司未披露,未能獲取相關數據
Co-Diagnostics Inc 簡介
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
行業醫療設備與耗材
公司代碼CODX
員工數量132
國家United States of America
持股情況
| 持股股東 | 佔比 |
|---|
| Orca Capital GmbH | 1.74% |
|---|
| Private Advisory Group LLC | 1.15% |
|---|
| Egan (Dwight H.) | 0.82% |
|---|
| Renaissance Technologies LLC | 0.68% |
|---|
| 股東類型 | 佔比 |
|---|
| Investment Advisor | 3.59% |
|---|
| Individual Investor | 3.39% |
|---|
| Hedge Fund | 0.72% |
|---|
| Investment Advisor/Hedge Fund | 0.56% |
|---|
常見問題
Co-Diagnostics Inc(CODX)的當前股價是多少?
Co-Diagnostics Inc(CODX)的當前股價是 0.94。
Co-Diagnostics Inc 的股票代碼是什麼?
Co-Diagnostics Inc的股票代碼是CODX。
Co-Diagnostics Inc股票的52週最高點是多少?
Co-Diagnostics Inc股票的52週最高點是13.54。
Co-Diagnostics Inc股票的52週最低點是多少?
Co-Diagnostics Inc股票的52週最低點是4.98。
Co-Diagnostics Inc的市值是多少?
Co-Diagnostics Inc的市值是4.61M。
現在Co-Diagnostics Inc(CODX)的股票是買入、持有還是賣出?
根據分析師評級,Co-Diagnostics Inc(CODX)的總體評級為買入,目標價格為4.00。
Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是多少
Co-Diagnostics Inc(CODX)股票的每股收益(EPS TTM)是-1054.65。